NCT03765242View on ClinicalTrials.gov

Evaluation of Safety and Effectiveness on Oral Anticoagulants

CompletedOBSERVATIONAL
Enrollment

12,354

Participants

Timeline

Start Date

September 21, 2018

Primary Completion Date

December 25, 2020

Study Completion Date

December 25, 2020

Conditions
Atrial Fibrillation
Interventions
OTHER

Non-Interventional

Non-Interventional

Trial Locations (1)

1080074

Local Institution, Minato-ku

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY

NCT03765242 - Evaluation of Safety and Effectiveness on Oral Anticoagulants | Biotech Hunter | Biotech Hunter